PharmaShots

MAY 12, 2023

Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD Date: May 12, 2023 | Tags: Sanofi, Nirsevimab, RSV-Related LRTD, Clinical Trial, P-IIIb, HARMONIE Trial G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023 (..)

FDA 40

FDA Chemotherapy Immunization Hospitals 40

PharmaShots

MARCH 31, 2023

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

FDA 40

FDA 40

STAT

AUGUST 2, 2023

health care system billions annually even as it remains out of reach for many lower-income seniors most likely to suffer from dementia , KFF Health News explains. Besides the $26,500 annual price tag, treatment could cost U.S. The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S.

Insurance Coverage 73

Insurance Coverage Insurance 73

The Checkup by Singlecare

JANUARY 15, 2023

The treatment of Alzheimer’s disease is garnering more attention and capturing headlines as the prevalence of dementia in older adults climbs. Boosting acetylcholine levels can offset the deficit in the brains of those with Alzheimer’s dementia. Alzheimer’s disease, Parkinson’s disease-related dementia. Alzheimer’s disease.

Dosage 52

Dosage FDA Insurance 52

pharmaphorum

OCTOBER 21, 2021

. “Every day that passes we estimate that over a thousand Americans move from mild to moderate Alzheimer’s dementia, and therefore may no longer be appropriate for initiation of treatment with Aduhelm,” he said on a conference call.

Insurance 119

Insurance FDA 119

pharmaphorum

JUNE 8, 2021

It also takes issue with the decision to approve the drug for all Alzheimer’s patients, rather than just the patients with mild cognitive impairment (MCI) and mild dementia included in Biogen’s studies of the drug. The post FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag appeared first on.

FDA 98

FDA Labelling 98

The Checkup by Singlecare

JANUARY 19, 2023

There may also be skin tags in these areas. Diabetes People with diabetes have a fasting blood sugar of 126 mg/dl or more. People with insulin resistance or prediabetes may not have any symptoms. There may be darkened skin in the armpits or around the neck—this is called acanthosis nigricans.

Immunization 105

Immunization Hospitals Communication 105